The Role of Transscleral Cyclophotocoagulation in Patients Undergoing a Boston Keratoprosthesis

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 30, 2020

Primary Completion Date

December 1, 2034

Study Completion Date

December 1, 2036

Conditions
GlaucomaEye DiseasesCornea Disease
Interventions
PROCEDURE

Transscleral cyclphophotocoagulation using the Micropulse system ( IRIDEX IQ810 Laser systems, Mountain View, CA).

Treatment will be applied over the limbal area to treat the ciliary body. The treatment will be delivered with an energy of 2000mW, a cycle of 31,33% and an on/off time of 0,5ms and 1,1ms. It will be delivered around a 360° surface with avoidance of the 3 and 9 o'clock areas. The treatment will be delivered during 80 secondes in each hemisphere and will be repeated twice, for a total of 320 secondes.

PROCEDURE

G-Probe transscleral cyclphophotocoagulation (Iris Medical Instruments, Montain View, CA)

"Treatment will be applied over the limbal area to treat the ciliary body. Sixteen (16) shots in total, which is four (4) shorts per quadrants, will be transmitted with a power from 1750 to 2000mV (titrating according to an audible pop) for a length of 2,0 secondes per shots. Treatment will be delivered around a 360° surface and avoiding the 3 and 9 o'clock areas."

Trial Locations (1)

H2X 3E4

RECRUITING

Centre Hospitalier de l'Université de Montréal (CHUM), Montreal

All Listed Sponsors
collaborator

Fonds de recherche en ophtalmologie de l'Université de Montréal

OTHER

lead

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER